News & Press
New Human Health Frontiers | IndieBio | SOSV
Vanguard technologies are democratizing access to health care and solving critically unmet needs. Hear from founders taking the most recent discoveries from the bench to the clinic for better diagnostic and therapeutic options.
The World Health Organization announced that antibiotic-resistant bacterial infections are a leading threat to global health, a threat exacerbated by improperly prescribed drugs. RizLab Health helps clinicians cut antibiotic dependency by pinpointing the source of infection (and thus choosing the correct clinical course) with their point-of-care device that differentiates bacterial from viral infection profiles within minutes. No longer will pediatricians prescribe antibiotics for every earache when they can quickly determine that a child has a common cold virus, and this is just the beginning of applications of the RizLab technology!
RizLab CEO Mehdi Javanmard, Ph.D.
The Next Generation of Diagnostic Wereables
Rizlab Health is transforming the diagnostic device ecosystem with their rapid and portable hematology analyzer, Cytotracker.
New device rapidly provides white blood cell count with a single drop of blood
The development of the device by researchers at Rutgers startup RizLab Health Inc. along with the clinical validation is described in the science and medical journal PLOS One.
Handheld white blood cell analyzer for near-patient testing
The device presented can transform care for infectious disease, oncology, and psychiatry patients.
Rutgers Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker
Device could enable rapid testing and improved triaging for infections and aid treatment for cancer or mental illness
Rizlab Health Inc. | Federal Award Analysis
Rizlab Health Federal Award History
A Data-driven Home Monitoring System for Classifying Viral/Bacterial Infections
RizLab Health DRIVe portfolio